VIR biotechnology - OTA for pre-exposure prophylactic monoclonal antibodies for the prevention of influenza illness and medical countermeasures for other emerging pathogens of pandemic potential
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50122C00081
- Awardee
-
VIR Biotechnology, Inc. UEI VAGNEFK9N5X7
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $65,867,804
Award facts
- Opportunity
-
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Pre-Solicitation · BAA18100SOL00003 · Posted Oct 16, 2017
- Contract value 100% obligated
- $65,867,803.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Sharing
- Place of performance
- San Francisco, CA 94158, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$8,358,582 | |
| Funding Only Action | -$42,074,016 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $61,300,401 | |
| Original award | $55,000,000 |
About this award
This is a $65,867,803.99 definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) to VIR Biotechnology, Inc., a self-certified small disadvantaged business. The contract is for the development of pre-exposure prophylactic monoclonal antibodies for the prevention of influenza illness and medical countermeasures for other emerging pathogens with pandemic potential. This contract was awarded under a Broad Agency Announcement (BAA) from BARDA seeking proposals for the advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear and pandemic influenza threats. The contract has no set-aside designation and will be performed in San Francisco, California over a term ending on December 31, 2024.
Quick answers
Who was awarded contract 75A50122C00081?
75A50122C00081 was awarded to VIR Biotechnology, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 30, 2022.
How much is contract 75A50122C00081 worth?
The government has obligated $65,867,804 on 75A50122C00081.
Was contract 75A50122C00081 competed?
The extent of competition for 75A50122C00081 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award